SBC Medical Group Holdings Incorporated Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for SBC Medical Group Holdings Incorporated (SBC) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022
Period EndingDec 2024Dec 2023Dec 2022
Operating Activities
Net Income46.6139.376.32
Depreciation & Amortization3.8012.255.93
Deferred Income Tax-14.424.11-3.90
Stock Based Compensation13.020.000.00
Change in Working Capital-46.88-7.65-10.59
Change in Accounts Receivable0.62-23.00-2.86
Change in Inventory1.12-1.83-0.67
Change in Accounts Payable-8.9125.54-8.37
Change in Other Working Capital-50.953.303.40
Other Operating Activities-10.473.303.40
Net Cash from Operating Activities20.5850.67-0.05
Investing Activities
Capital Expenditures-3.41-11.21-24.95
Acquisitions-4.240.72-6.49
Purchases of Investments-0.33-2.13-2.65
Sales/Maturities of Investments0.004.130.00
Other Investing Activities-1.302.58-0.34
Net Cash from Investing Activities-10.101.79-32.65
Financing Activities
Debt Repayment-0.86-8.73-5.21
Common Stock Issued0.030.000.00
Other Financing Activities11.712.56-2.89
Net Cash from Financing Activities22.976.14-7.98
Summary
Effect of Forex Changes on Cash-11.42-7.31-12.09
Net Change in Cash22.0258.60-40.68
Cash at Beginning of Period103.0251.74104.50
Cash at End of Period125.04103.0251.74
Free Cash Flow17.1739.46-24.99
Supplemental Disclosures
Interest Paid0.030.050.03
Income Taxes Paid30.2417.8430.82